Publications of the Week A Curious Case for Development of Kinase Inhibitors as Antigiardiasis Treatments Using Advanced Drug TechniquesMichaels, S. A., et al. | February 19, 2021In this manuscript we discuss emerging drug development tools that can be used to accelerate…emcguinnFebruary 19, 2021 Read More
Local News Seagen and Astellas Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV® in Patients with Previously Treated Advanced Urothelial CancerSeagen | February 18, 2021Seagen Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D.,…emcguinnFebruary 18, 2021 Read More
Publications of the Week T Cells Specific for a Mycobacterial Glycolipid Expand after Intravenous Bacillus Calmette–Guérin VaccinationLayton, E. D., et al. | February 18, 2021Peptide antigens are typically presented to T cells by highly polymorphic major histocompatibility complex (MHC)…emcguinnFebruary 18, 2021 Read More
Local News 11 Things to Know About mRNA Vaccines for COVID-19Benaroya Research Institute at Virginia Mason | February 17, 2021In the race for a COVID-19 vaccine, messenger RNA (mRNA) vaccines finished first. This includes…emcguinnFebruary 17, 2021 Read More
Local News European Commission Approves Seagen’s TUKYSA® for the Treatment of Patients with Locally Advanced or Metastatic HER2-Positive Breast CancerSeagen | February 17, 2021Seagen Inc. (Nasdaq:SGEN) today announced that the European Commission (EC) has granted marketing authorization for…emcguinnFebruary 17, 2021 Read More
Local News Fred Hutch Biotech Spinout Ozette Raises $6M from Madrona, AI2, VulcanGeekWire | February 17, 2021New funding: Ozette, a biotech company that last year spun out of the Fred Hutchinson Cancer Research…emcguinnFebruary 17, 2021 Read More
Local News Fred Hutch, Univ. of Washington Biotech Spinout Ensoma Launches with $70M in FundingGeekWire | February 16, 2021Boston-based biotech startup Ensoma launched Thursday and announced a $70 million Series A funding round. The company…emcguinnFebruary 16, 2021 Read More
Local News New Allen Distinguished Investigators Will Tackle Unanswered Questions About Metabolism and the Immune SystemAllen Institute | February 15, 2021Just like us, immune cells need fuel to do their jobs. Despite the tight links between human health — including…emcguinnFebruary 15, 2021 Read More
Publications of the Week Residual β Cell Function in Long-Term Type 1 Diabetes Associates with Reduced Incidence of HypoglycemiaGubitosi-Klug, R., et al. | February 12, 2021We investigated residual β cell function in Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions…emcguinnFebruary 12, 2021 Read More
Local News What’s Next for T-Cell Therapies: Q&A with Dr. Stanley RiddellFred Hutch | February 12, 2021Today’s Food and Drug Administration approval of Bristol Myers Squibb’s liso-cel for the treatment of…emcguinnFebruary 12, 2021 Read More